The effect of fibrin on the survival of ischemic skin flaps in rats

Plastic and Reconstructive Surgery

Volumn 120, Issue 5, 2007, Pages 1148-1155

  Qi, Zhi ^a   Gu, Yuanjun ^a   Kim, Dohoon ^a   Hiura, Akihito ^a   Sumi, Shoichiro ^a   Inoue, Kazutomo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; PHOSPHATE BUFFERED SALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GRAFT NECROSIS; HISTOLOGY; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN BLOOD FLOW; SKIN FLAP SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; ENDOTHELIAL CELLS; FIBRIN; ISCHEMIA; MALE; NECROSIS; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; SURGICAL FLAPS; TISSUE SURVIVAL;

EID: 34848832700     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000279524.05541.5b     Document Type: Article

References (27)

1. Rinsch, C., Quinodoz, P., Pittet, B., et al. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther. 8: 523, 2001.
2. Hijjawi, J., Mogford, J. E., Chandler, L. A., et al. Platelet-derived growth factor B, but not fibroblast growth factor 2, plasmid DNA improves survival of ischemic myocutaneous flaps. Arch. Surg. 139: 142, 2004.
3. Alizadeh, N., Pittet, B., Tenorio, X., et al. Active-site inactivated FVIIa decreases thrombosis and necrosis in a random skin flap model of acute ischemia. J. Surg. Res. 122: 263, 2004.
4. Hsu, O. K., Gabr, E., Steward, E., et al. Pharmacologic enhancement of rat skin flap survival with topical oleic acid. Plast. Reconstr. Surg. 113: 2048, 2004.
5. Kryger, Z., Zhang, F., Dogan, T., Cheng, C., Lineaweaver, W. C., and Buncke, H. J. The effects of VEGF on survival of a random flap in the rat: Examination of various routes of administration. Br. J. Plast. Surg. 53: 234, 2000.
6. Taran, A., Har-Shai, Y., Lindenbaum, E., et al. Improved vitality of experimental random dorsal skin flaps in rats treated with enriched cell culture medium. Plast. Reconstr. Surg. 104: 148, 1999.
7. Ercocen, A. R., Kono, T., Kikuchi, Y., Kitazawa, Y., and Nozaki, M. Efficacy of the flashlamp-pumped pulsed-dye laser in nonsurgical delay of skin flaps. Dermatol. Surg. 29: 692, 2003.
8. Karaçal, N., Ambarcioǧlu, O., Topal, U., Mamedov, T., and Kutlu, N. Enhancement of dorsal random-pattern skin flap survival in rats with topical lidocaine and prilocaine (EMLA): Enhancement of flap survival by EMLA. J. Surg. Res. 124: 134, 2005.
9. Shimpo, M., Ikeda, U., Maeda, Y., et al. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc. Res. 53: 993, 2002.
10. Zhang, F., Lei, M. P., Oswald, T. M., et al. The effect of vascular endothelial growth factor on the healing of ischaemic skin wounds. Br. J. Plast. Surg. 56: 334, 2003.
11. Taub, P. J., Marmur, J. D., Zhang, W. X., et al. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps. Plast. Reconstr. Surg. 102: 2033, 1998.
12. Bayati, S., Russell, R. C., and Roth, A. C. Stimulation of angiogenesis to improve the viability of prefabricated flaps. Plast. Reconstr. Surg. 101: 1290, 1998.
13. Van Hinsbergh, V. W., Collen, A., and Koolwijk, P. Role of fibrin matrix in angiogenesis. Ann. N. Y. Acad. Sci. 936: 426, 2001.
14. Kroon, M. E., Koolwijk, P., van der Vecht, B., and van Hinsbergh, V. W. Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: Involvement of at least two signal transduction pathways. J. Cell Sci. 14: 825, 2001.
15. Li, J., Zhang, Y. P., and Kirsner, R. S. Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60: 107, 2003.
16. Collen, A., Koolwijk, P., Kroon, M., and van Hinsbergh, V. W. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis 2: 153, 1998.
17. Martinez, J., Ferber, A., Bach, T. L., and Yaen, C. H. Interaction of fibrin with VE-cadherin. Ann. N. Y. Acad. Sci. 936: 386, 2001.
18. Chalupowicz, D. G., Chowdhury, Z. A., Bach, T. L., Barsigian, C., and Martinez, J. Fibrin II induces endothelial cell capillary tube formation. J. Cell Biol. 130: 207, 1995.
19. Hall, H., Baechi, T., and Hubbell, J. A. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. Microvasc. Res. 62: 315, 2001.
20. Burbridge, M. F., Coge, F., Galizzi, J. P., Boutin, J. A., West, D. C., and Tucker, G. C. The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis 5: 215, 2002.
21. Gorlatov, S., and Medved, L. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: Mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. Biochemistry 41: 4107, 2002.
22. Nehls, V., and Herrmann, R. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc. Res. 325: 1650, 1996.
23. Nohira, K., Shintomi, Y., Ikawa, H., et al. Development of skin blood flow monitoring system using laser speckle phenomena (in Japanese with English abstract). J. Jpn. Soc. Plast. Reconstr. Surg. 6: 467, 1986.
24. Atalay, C., Kockaya, E. A., Cetin, B., and Akay, M. T. The role of fibrin tissue adhesives in flap necrosis in rats. J. Invest. Surg. 18: 97, 2005.
25. Kulber, D. A., Bacilious, N., Peters, E. D., Gayle, L. B., and Hoffman, L. The use of fibrin sealant in the prevention of seromas. Plast. Reconstr. Surg. 9: 842, 1997.
26. Currie, L. J., Sharpe, J. R., and Martin, R. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: A review. Plast. Reconstr. Surg. 108: 1713, 2001.
27. McFarlane, R. M., Deyong, G., and Henry, R. A. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast. Reconstr. Surg. 35: 177, 1965.